Knowledge Ridge

Expert Views

Delivering Insights

Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.

Personalized Skincare Takes the Lead
14 Apr 2026

Personalized Skincare Takes the Lead

Co-Founder (Oct 2023 – Present); India

As consumers shift to clinically driven skincare, expectations on efficacy and timelines are rising, while misinformation, overuse of actives, and self-diagnosis are increasing, pushing demand toward preventive, personalized, and medically guided treatments.

Scaling Ophthalmics in Emerging Markets
14 Apr 2026

Scaling Ophthalmics in Emerging Markets

Former Cluster Head – India, APAC and LATAM at Biotech Vision Care Private Limited (Jan 2021 – Dec 2025); India

Rising ophthalmic demand across India, APAC, and LATAM is driven by aging populations, lifestyle diseases, and access expansion, while companies adapt go-to-market models, navigate global–regional competition, and leverage AI for smarter growth prioritization.

Pharma GCCs: From Cost to Capability
13 Apr 2026

Pharma GCCs: From Cost to Capability

Independent Consultant/Advisor, Lead SME, GCC Consultant/advisor, Startup Mgmt. Consultant, Advisor (Nov 2025 - Present); India

The article explores the evolution of pharma Global Capability Centers, highlighting their shift from cost-saving to innovation, the impact of AI and compliance, and the growing importance of talent and decision rights.

Healthcare Market Shifts: Ground View
07 Apr 2026

Healthcare Market Shifts: Ground View

Zonal Sales Manager (Jan 2026 - Present); India

An industry expert shares on-the-ground insights on regulatory changes, hospital procurement, AI-driven engagement, and supply challenges shaping India’s pharmaceutical and healthcare landscape.

Digital Twins In Pharma
31 Mar 2026

Digital Twins In Pharma

Founding Scientist

Digital twins can prevent $2M failed batches and help pharma companies avoid $50–$200M revenue risks from regulatory issues. Read the full article to learn how digital twins provide solutions.

AI in Pharma: Real Impact vs Commercial Illusion
31 Mar 2026

AI in Pharma: Real Impact vs Commercial Illusion

Head of Marketing (Dec 2014 – Present)

Pharma’s shift to data-driven commercialization is reshaping decisions amid rising compliance, pricing, and ESG pressures. While AI shows selective gains, ROI gaps persist, exposing value chain vulnerabilities and execution challenges in high-growth segments.